Risk factors

Credit exposure centers on Western and Central New York, small and midsized businesses, commercial loans, and commercial real estate oversight.

Heavy reliance on foreign manufacturing in China and foreign-held cash presents significant geopolitical and supply chain vulnerabilities. Substantial debt and a recent history of net losses threaten ongoing liquidity and operations. Extensive reliance on licensed fashion brand names creates severe revenue concentration risks.

Heavy reliance on single customer ProFrac representing 62% of 2024 revenue creates extreme concentration risk. Operations depend on volatile oil and gas commodity prices and hydraulic fracturing activity. Strict environmental regulations and potential changes under the Trump administration threaten product demand.

Rapid portfolio growth in multi-family and commercial real estate elevates concentration risks.

Hudson Technologies depends heavily on refrigerant market prices, weather conditions, and environmental regulations governing greenhouse gases.

Commercial lending heavily concentrates in Central Indiana and represents eighty percent of total loans. Operations depend entirely on digital channels and third-party fintech partnerships. Strict regulatory oversight governs capital, liquidity, and compliance across multiple federal agencies.

Isabella Bank Corp is exposed heavily to credit risk and loan concentration across eight Michigan counties.

Investar Holding Corporation faces dominant risks from fluctuating interest rates affecting its cost of deposits and net interest margin. Regional economic concentration in southern Louisiana, Texas, and Alabama exposes the bank to local downturns and severe weather. Extensive federal and state banking regulations, compliance burdens, and competitive pressures heavily shape operational risks.

Kodiak AI is a blank check company holding $550,800,038 in trust, currently seeking an initial business combination.

KORU Medical faces heavy customer concentration with distributors and relies on single-source suppliers for subassemblies and therapies. Compliance with EU MDR regulations by December 2028 is critical for international sales. The company operates entirely within the infusion market and depends on third-party drug availability.

LCNB Corp's risk profile is dominated by geographic concentration in Ohio, heavy exposure to real estate and commercial loans, and strict banking regulations.

Manhattan Bridge Capital is constrained by limited working capital and heavy reliance on a single credit facility maturing in 2026. The business faces significant geographic concentration in the New York metropolitan area and strict REIT compliance obligations. Key vulnerabilities include borrower defaults, key executive dependence, and rising interest rates.